Beginner’s Guide to the Human Gut Microbiome
Moderator: Sabine Hazan, MD
Speaker: Neil Stollman, MD (UCSF)
Objective: Become familiar with the human gut microbiome and its role in health
Making sense of metagenomics
Speaker: Andreas Papoutsis, PhD (Progenabiome)
Objective: Understand methods used to study the composition and function of the gut microbiome.
Disease associations (cause or consequence)?
Speaker: Sabine Hazan, MD (Progenabiome)
Understand the value of genetic sequencing in fecal transplant in non C. diff conditions.
Principles guiding research, regulation and product development
Moderator: Howard Young, MD, PhD (NIH)
Connecting the dots: how scientists elucidate mechanisms of microbial influence.
Speaker: Howard Young, PhD (NIH)
Objective: Understand principles guiding investigations around human immune and gut microbial interactions
Taming the Wild West: Developing Standards for Microbiome Research and Product Development
Speaker: Scott Jackson, PhD (NIST)
Objective: Describe the importance of standards for microbiome measurements to support research investigations and clinical/commercial translation of microbiome science.
Microbiome Based Therapeutics: Opportunities and Challenges
Speaker: Zain Kassam, MD (Finch)
Objective: Gain insight into how industry is working to develop treatment options and the complexities of trial design in this space.
Microbiome Therapeutics: Thinking outside the box
Speaker: Thomas Borody, MD (CDD Australia)
Evidence of efficacy and safety of FMT for C. difficile infection
Speaker: Colleen Kelly, MD (Brown)
Objective: Review evidence from randomized controlled trials of FMT in C. difficile.
Pharmacology of FMT
Speaker: Alexander Khoruts, MD (University of Minnesota)
Objective: Describe mechanisms driving the therapeutic effects of FMT
Challenges Around Clinical Trials in C. difficile
Speaker: Paul Feuerstadt, MD (Yale)
Objective: Describe unique challenges to conducting clinical trials of microbiome-based therapies in C. difficile.
Expanding Applications of FMT
Manipulating the Microbiome to treat IBD
Speaker: Jessica Allegretti, MD (Brigham and Womens, Harvard)
Objective: Review dysbiosis in inflammatory bowel disease and evidence from randomized controlled trials of FMT in the IBD population.
Microbiota and the Metabolic Syndrome: New Horizons and New Opportunities
Speaker: Mazen Noureddin, MD (Cedars Sinai)
Objective: Describe the evidence for how gut microbes influence metabolism and drive features of the metabolic syndrome, including nonalcoholic steatohepatitis.
Implications of the Gut Microbiome in Cancer and Therapeutic Potential
Speaker: Yinghong Wang, MD, PhD (MD Anderson)
Objective: Describe how gut microorganisms impact the metabolism of cancer therapies and how microbial manipulation may transform patient care.
Microbiota Transplant for Autism
Speaker: James B. Adams, PhD (Arizona State University)
Objective: Review a Phase 1 clinical trial of microbiota transplant for children with autism.
Microbiome based Therapies for Recurrent Urinary Tract Infections
Speaker: Sahil Khanna, MD (Mayo Clinic)
Objective: Examine the role of microbiome based therapy in chronic UTI.
Panel Discussions, Announcements, and more!
Copyright © 2020 Malibu Microbiome Meeting - All Rights Reserved.
CME activities are jointly provided by Medical Resource Association, Inc. and AKH Inc., Advancing Knowledge in Healthcare. AKH, Inc. is proud to have received Accreditation with Commendation from the Accreditation Council for Continuing Medical Education.
Please contact Charles Messal 941-726-8425 or Kristen M. Beury 941-726-3169 regarding any CME Activity related questions. Thank you!
*Agenda/Topics/Speakers subject to change without notice